US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

The Health Care Select Sector SPDR Premium Income Fund

26.00

-0.0500-0.19%

Volume:19.42K

Turnover:507.28K

Market Cap:26.52M

PE:- -

High:26.20

Open:26.00

Low:26.00

Close:26.05

52wk High:27.35

52wk Low:24.20

Shares:1.02M

Float Shares:1.02M

Volume Ratio:0.18

T/O Rate:1.90%

Dividend:3.27

Dividend Rate:12.57%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal

India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/XLVI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLVI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLVI\",,,,,undefined,":{"symbol":"XLVI","market":"US","secType":"STK","nameCN":"The Health Care Select Sector SPDR Premium Income Fund","latestPrice":26,"timestamp":1789588800000,"preClose":26.05,"halted":0,"volume":19416,"delay":0,"changeRate":-0.0019193857965451328,"floatShares":1020000,"shares":1020000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"09-17 06:03:30 EDT","open":26,"high":26.2,"low":26,"amount":507283.98717599997,"amplitude":0.007678,"askPrice":41.34,"askSize":100,"bidPrice":10.46,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":26,"sharesOutstanding":490000,"nav":26.033764,"aum":26554439.09,"dividendRate":0.125652,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":26,"preClose":26,"latestTime":"19:30 EDT","volume":10,"amount":260,"timestamp":1789601403922,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.18139691322198082},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLVI\",,,,,undefined,":{"symbol":"XLVI","floatShares":1020000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.18139691322198082,"shares":1020000,"dividePrice":3.266961,"high":26.2,"amplitude":0.007678,"preClose":26.05,"low":26,"week52Low":24.2,"pbRate":"--","week52High":27.35,"institutionHeld":0,"latestPrice":26,"eps":0,"divideRate":0.125652,"volume":19416,"delay":0,"ttmEps":0,"open":26,"prevYearClose":26.4307,"prevWeekClose":25.71,"prevMonthClose":26.92,"prevQuarterClose":26.3599,"fiveDayClose":25.87,"twentyDayClose":27.22,"sixtyDayClose":25.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLVI\",params:#limit:5,,,undefined,":[{"date":"2026-09-01","symbol":"XLVI","amount":0.284682,"announcedDate":"2026-08-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-01","defaultRemindTime":1788269400000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-03","payableDate":"2026-09-01","currency":"USD","dateTimestamp":1788235200000,"payDate":"2026-09-03"},{"date":"2026-08-03","symbol":"XLVI","amount":0.220362,"announcedDate":"2026-07-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-03","defaultRemindTime":1785763800000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-05","payableDate":"2026-08-03","currency":"USD","dateTimestamp":1785729600000,"payDate":"2026-08-05"},{"date":"2026-07-01","symbol":"XLVI","amount":0.265104,"announcedDate":"2026-06-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-06","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-06"},{"date":"2026-06-01","symbol":"XLVI","amount":0.20398,"announcedDate":"2026-05-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-01","defaultRemindTime":1780320600000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-03","payableDate":"2026-06-01","currency":"USD","dateTimestamp":1780286400000,"payDate":"2026-06-03"},{"date":"2026-05-01","symbol":"XLVI","amount":0.266919,"announcedDate":"2026-04-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-01","defaultRemindTime":1777642200000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-05","payableDate":"2026-05-01","currency":"USD","dateTimestamp":1777608000000,"payDate":"2026-05-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLVI\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-02","recordDate":"2025-09-02","paymentDate":"2025-09-05","value":0.373503,"currency":"USD"},{"executeDate":"2025-10-01","recordDate":"2025-10-01","paymentDate":"2025-10-03","value":0.293409,"currency":"USD"},{"executeDate":"2025-11-03","recordDate":"2025-11-03","paymentDate":"2025-11-05","value":0.244969,"currency":"USD"},{"executeDate":"2025-12-01","recordDate":"2025-12-01","paymentDate":"2025-12-03","value":0.273076,"currency":"USD"},{"executeDate":"2025-12-29","recordDate":"2025-12-29","paymentDate":"2025-12-31","value":0.329285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLVI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLVI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","PINK","CURE","NVOC","NVOH","MEDI","RSPH","BGIA","NVOX","NBDS","FHLC","TRUH","XLVI","FXH","IYH","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131442769","title":"Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1131442769","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131442769?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:22","pubTimestamp":1788182577,"startTime":"0","endTime":"0","summary":"Eli Lilly and Co (NYSE: LLY) is set to acquire Merida Biosciences Inc. for up to $2.88 billion in cash, marking a strategic push into autoimmune and allergic disease treatments as the pharma giant...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","NVOH","PJP","XLVI","TRUH","FXH","CURE","MEDI","NVOX","IYH","FHLC","PINK","NBDS","THNR","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128151773","title":"India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=1128151773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128151773?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:56","pubTimestamp":1787954186,"startTime":"0","endTime":"0","summary":"India's weight-loss drug market is delivering a sobering lesson to the global pharmaceutical industry about market expectations. Despite large-scale generic production of GLP-1 medications and prices...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDN","LLYX","RSPH","UUP","MNDmain","ELIS","NVOH","NBDS","FHLC","NVOX","PINK","MEDI","CURE","NVOC","FXH","THNR","LLII","XLVI","TRUH","IYH","OZEM","PJP","ELIL","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBP","161027","BK4588","XLVI","06881","WRND","GSKH","BK0188","601881","BK4585","PBE","BK0276","BK1147","LFSC","BIOY","BK1564","GDOC","APXH","IBB","SBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XLVI\",params:#limit:6,delay:false,,,undefined,":[]}}